Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Claudins and JAM-A coordinately regulate tight junction formation and epithelial polarity.

Otani T, Nguyen TP, Tokuda S, Sugihara K, Sugawara T, Furuse K, Miura T, Ebnet K, Furuse M.

J Cell Biol. 2019 Aug 29. pii: jcb.201812157. doi: 10.1083/jcb.201812157. [Epub ahead of print]

PMID:
31467165
2.

Septate junctions regulate gut homeostasis through regulation of stem cell proliferation and enterocyte behavior in Drosophila.

Izumi Y, Furuse K, Furuse M.

J Cell Sci. 2019 Aug 23. pii: jcs.232108. doi: 10.1242/jcs.232108. [Epub ahead of print]

PMID:
31444286
3.

Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens.

Furuse K, Ukai W, Hashimoto E, Hashiguchi H, Kigawa Y, Ishii T, Tayama M, Deriha K, Shiraishi M, Kawanishi C.

J Affect Disord. 2019 Mar 15;247:97-104. doi: 10.1016/j.jad.2019.01.007. Epub 2019 Jan 5.

PMID:
30658246
4.

Antipsychotics promote GABAergic interneuron genesis in the adult rat brain: Role of heat-shock protein production.

Kaneta H, Ukai W, Tsujino H, Furuse K, Kigawa Y, Tayama M, Ishii T, Hashimoto E, Kawanishi C.

J Psychiatr Res. 2017 Sep;92:108-118. doi: 10.1016/j.jpsychires.2017.03.008. Epub 2017 Mar 10.

PMID:
28414930
5.

A tetraspanin regulates septate junction formation in Drosophila midgut.

Izumi Y, Motoishi M, Furuse K, Furuse M.

J Cell Sci. 2016 Mar 15;129(6):1155-64. doi: 10.1242/jcs.180448. Epub 2016 Feb 4.

6.

Stem cell therapy: a new approach to the treatment of refractory depression.

Kigawa Y, Hashimoto E, Ukai W, Ishii T, Furuse K, Tsujino H, Shirasaka T, Saito T.

J Neural Transm (Vienna). 2014 Oct;121(10):1221-32. doi: 10.1007/s00702-014-1194-2. Epub 2014 Mar 27.

7.

A weekly combination of carboplatin and irinotecan for previously untreated extensive disease small-cell lung cancer, results of a minimum follow-up of 3 years: a multi-center Phase II trial JMTO LC02-02.

Okishio K, Mio T, Kawahara M, Yoshioka H, Yanagihara K, Daimon T, Furuse K.

Jpn J Clin Oncol. 2012 May;42(5):387-93. doi: 10.1093/jjco/hys028. Epub 2012 Mar 19.

PMID:
22430871
8.

A phase I study of amrubicin and fixed dose of irinotecan (CPT-11) in relapsed small cell lung cancer: Japan multinational trial organization LC0303.

Kawahara M, Kubo A, Komuta K, Fujita Y, Sasaki Y, Fukushima M, Daimon T, Furuse K, Mishima M, Mio T.

J Thorac Oncol. 2012 Dec;7(12):1845-1849. doi: 10.1097/JTO.0b013e3181e47a62.

10.

Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules.

Muto S, Hata M, Taniguchi J, Tsuruoka S, Moriwaki K, Saitou M, Furuse K, Sasaki H, Fujimura A, Imai M, Kusano E, Tsukita S, Furuse M.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):8011-6. doi: 10.1073/pnas.0912901107. Epub 2010 Apr 12.

11.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP.

J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29. Review.

PMID:
20351327
12.

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03.

Kishida Y, Kawahara M, Teramukai S, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Atagi S, Kawaguchi T, Furuse K, Fukushima M.

Br J Cancer. 2009 Nov 3;101(9):1537-42. doi: 10.1038/sj.bjc.6605348. Epub 2009 Sep 29.

13.

Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.

Iwamoto Y, Tanaka K, Isu K, Kawai A, Tatezaki S, Ishii T, Kushida K, Beppu Y, Usui M, Tateishi A, Furuse K, Minamizaki T, Kawaguchi N, Yamawaki S.

J Orthop Sci. 2009 Jul;14(4):397-404. doi: 10.1007/s00776-009-1347-6. Epub 2009 Aug 7.

PMID:
19662473
14.

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer - a retrospective analysis: JMTO LC03-02.

Nakagawa M, Nishimura T, Teramukai S, Tada H, Tanaka F, Yanagihara K, Furuse K, Wada H, Fukushima M.

BMC Res Notes. 2009 Aug 5;2:157. doi: 10.1186/1756-0500-2-157.

15.

Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004.

Isa S, Kawaguchi T, Teramukai S, Minato K, Ohsaki Y, Shibata K, Yonei T, Hayashibara K, Fukushima M, Kawahara M, Furuse K, Mack PC.

J Thorac Oncol. 2009 Sep;4(9):1104-10. doi: 10.1097/JTO.0b013e3181ae2844.

16.

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.

Gandara DR, Kawaguchi T, Crowley J, Moon J, Furuse K, Kawahara M, Teramukai S, Ohe Y, Kubota K, Williamson SK, Gautschi O, Lenz HJ, McLeod HL, Lara PN Jr, Coltman CA Jr, Fukuoka M, Saijo N, Fukushima M, Mack PC.

J Clin Oncol. 2009 Jul 20;27(21):3540-6. doi: 10.1200/JCO.2008.20.8793. Epub 2009 May 26.

17.

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.

Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K, Fukushima M.

Eur J Cancer. 2009 Jul;45(11):1950-8. doi: 10.1016/j.ejca.2009.01.023. Epub 2009 Feb 21.

PMID:
19231158
18.

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.

Kubota K, Kawahara M, Ogawara M, Nishiwaki Y, Komuta K, Minato K, Fujita Y, Teramukai S, Fukushima M, Furuse K; Japan Multi-National Trial Organisation.

Lancet Oncol. 2008 Dec;9(12):1135-42. doi: 10.1016/S1470-2045(08)70261-4. Epub 2008 Nov 13.

PMID:
19013107
19.

Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.

Takeda K, Takifuji N, Negoro S, Furuse K, Nakamura S, Takada Y, Hoso T, Hayasaka S, Nakano T, Araki J, Senba H, Iwami F, Yamaji Y, Fukuoka M, Ikegami H.

Invest New Drugs. 2007 Aug;25(4):377-83. Epub 2007 Mar 10.

PMID:
17351748
20.

Photon emissions from rice cells elicited by N-acetylchitooligosaccharide are generated through phospholipid signaling in close association with the production of reactive oxygen species.

Kageyama C, Kato K, Iyozumi H, Inagaki H, Yamaguchi A, Furuse K, Baba K.

Plant Physiol Biochem. 2006 Nov-Dec;44(11-12):901-9. Epub 2006 Oct 6.

PMID:
17123826
21.

Normal establishment of epithelial tight junctions in mice and cultured cells lacking expression of ZO-3, a tight-junction MAGUK protein.

Adachi M, Inoko A, Hata M, Furuse K, Umeda K, Itoh M, Tsukita S.

Mol Cell Biol. 2006 Dec;26(23):9003-15. Epub 2006 Sep 25.

22.

Molecular characterization of water-selective AQP (EbAQP4) in hagfish: insight into ancestral origin of AQP4.

Nishimoto G, Sasaki G, Yaoita E, Nameta M, Li H, Furuse K, Fujinaka H, Yoshida Y, Mitsudome A, Yamamoto T.

Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R644-51. Epub 2006 Sep 21.

23.

ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation.

Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, Matsui T, Tsukita S, Furuse M, Tsukita S.

Cell. 2006 Aug 25;126(4):741-54.

24.

Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells.

Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S.

J Cell Biol. 2005 Dec 19;171(6):939-45.

25.

[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].

Hatae M, Ariyoshi Y, Fukuoka M, Furuse K, Noda K, Hirabayashi K, Yakushiji M, Ogawa M, Takaku F.

Gan To Kagaku Ryoho. 2005 Apr;32(4):489-96. Japanese.

PMID:
15853215
26.

[Analysis of factors affecting prolonged hospitalizations in elderly patients with community-acquired pneumonia].

Tanaka MT, Kajitani M, Matsuda A, Hoshiya T, Furuse K, Kobayashi S.

Nihon Ronen Igakkai Zasshi. 2004 Nov;41(6):666-9. Japanese.

PMID:
15651386
27.

Compartmentalization established by claudin-11-based tight junctions in stria vascularis is required for hearing through generation of endocochlear potential.

Kitajiri S, Miyamoto T, Mineharu A, Sonoda N, Furuse K, Hata M, Sasaki H, Mori Y, Kubota T, Ito J, Furuse M, Tsukita S.

J Cell Sci. 2004 Oct 1;117(Pt 21):5087-96.

28.

Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.

Tsuji N, Furuse K, Asanuma K, Furuya M, Kondoh K, Kamagata C, Sasaki M, Kobayashi D, Yagihashi A, Takahashi H, Watanabe N.

Breast Cancer Res Treat. 2004 Sep;87(1):23-31.

PMID:
15377848
29.

JACOP, a novel plaque protein localizing at the apical junctional complex with sequence similarity to cingulin.

Ohnishi H, Nakahara T, Furuse K, Sasaki H, Tsukita S, Furuse M.

J Biol Chem. 2004 Oct 29;279(44):46014-22. Epub 2004 Jul 30.

30.

Establishment and characterization of cultured epithelial cells lacking expression of ZO-1.

Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, Tsukita S.

J Biol Chem. 2004 Oct 22;279(43):44785-94. Epub 2004 Jul 30.

31.

Consensus: the follow-up of the treated patient.

Saunders M, Sculier JP, Ball D, Capello M, Furuse K, Goldstraw P, Meert AP, Ninane V, Ohe Y, Paesmans M, Park K, Pirker R, Postmus P, Sokolow Y.

Lung Cancer. 2003 Dec;42 Suppl 1:S17-9. Review.

PMID:
14708519
32.

Critical factors for patient management.

Ninane V, Le Pechoux C, Curran W, Furuse K, Liptay M, Meert AP, Paesmans M, Rami-Porta R, Roelandts M, Ruckdeschel JC, Sculier JP, Senan S, Smit EF.

Lung Cancer. 2003 Dec;42 Suppl 1:S7-8.

PMID:
14708515
33.

[A resected case of malignant fibrous histiocytoma of the chest wall].

Miwa K, Nakamura H, Fukui H, Ikeda M, Furuse K.

Kyobu Geka. 2003 Aug;56(9):742-6. Japanese.

PMID:
12931582
34.

Expression of claudin-5 in dermal vascular endothelia.

Morita K, Sasaki H, Furuse K, Furuse M, Tsukita S, Miyachi Y.

Exp Dermatol. 2003 Jun;12(3):289-95.

PMID:
12823443
35.

Dynamic behavior of paired claudin strands within apposing plasma membranes.

Sasaki H, Matsui C, Furuse K, Mimori-Kiyosue Y, Furuse M, Tsukita S.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3971-6. Epub 2003 Mar 21.

36.

Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02).

Hosoe S, Komuta K, Shibata K, Harada H, Iwamoto Y, Ohsaki Y, Morioka T, Origasa H, Fukushima M, Furuse K, Kawahara M.

Br J Cancer. 2003 Feb 10;88(3):342-7.

37.

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer.

Naka N, Kawahara M, Okishio K, Hosoe S, Ogawara M, Atagi S, Takemoto Y, Ueno K, Kawaguchi T, Tsuchiyama T, Furuse K.

Lung Cancer. 2002 Sep;37(3):319-23.

PMID:
12234702
38.

Phase I studies of nogitecan hydrochloride for Japanese.

Kobayashi K, Hino M, Fukuoka M, Takeuchi K, Furuse K, Yoneda S, Hasegawa K, Noda K, Kinoshita H, Kimura I, Taguchi T, Kanamaru R, Horikoshi N, Niitani H.

Int J Clin Oncol. 2002 Jun;7(3):177-86.

PMID:
12109520
39.

Chromosome analysis of blastocysts cultured under the diabetic condition.

Tatewaki R, Kagohashi Y, Furuse K, Otani H.

Congenit Anom (Kyoto). 2002 Mar;42(1):21-6.

PMID:
12094076
40.

Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.

Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S.

J Cell Biol. 2002 Mar 18;156(6):1099-111. Epub 2002 Mar 11.

41.

Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.

Kunikane H, Watanabe K, Fukuoka M, Saijo N, Furuse K, Ikegami H, Ariyoshi Y, Kishimoto S.

Int J Clin Oncol. 2001 Dec;6(6):296-301.

PMID:
11828949
42.

Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.

Furuse K, Kawahara M, Hasegawa K, Kudoh S, Takada M, Sugiura T, Ichinose Y, Fukuoka M, Ohashi Y, Niitani H; S-1 Cooperative Study Group (Lung Cancer Working Group).

Int J Clin Oncol. 2001 Oct;6(5):236-41.

PMID:
11723745
43.

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer.

Kawahara M, Furuse K, Segawa Y, Yoshimori K, Matsui K, Kudoh S, Hasegawa K, Niitani H; S-1 Cooperative Study Group (Lung Cancer Working Group).

Br J Cancer. 2001 Sep 28;85(7):939-43.

44.
45.

[Autopsy case of adenoid cystic carcinoma of the trachea: endobronchial treatment improves quality of life].

Kawaguchi T, Nobuyama S, Mituoka S, Sunami T, Naka N, Okishio K, Ueno K, Atagi S, Inoue Y, Ogawara M, Hosoe S, Yotsumoto S, Kawahara M, Iuchi K, Yamamoto S, Furuse K.

Nihon Kokyuki Gakkai Zasshi. 2000 Oct;38(10):812-6. Japanese.

PMID:
11186931
46.

Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients.

Song MM, Nio Y, Dong M, Tamura K, Furuse K, Tian YL, He SG, Shen K.

J Surg Oncol. 2000 Nov;75(3):176-85.

PMID:
11088049
47.

Originality benefit and difficulty of clinical research in the West Japan Lung Cancer Group.

Kawahara M, Ariyoshi Y, Fukuoka M, Furuse K.

Crit Rev Oncol Hematol. 2000 Oct;36(1):9-12.

PMID:
10996519
49.

Synchronous primary adenocarcinoma of the lung and leiomyosarcoma of the small intestine.

Takemoto Y, Kawahara M, Yamamoto S, Iuchi K, Mori T, Ueda E, Tsuchiyama T, Furuse K.

Intern Med. 2000 Aug;39(8):655-8.

50.

Supplemental Content

Loading ...
Support Center